drug store, pharmacy, chain drug store, drugstore, community pharmacy, drug chain, retail pharmacy

Other Services
Reprints / E-Prints
Submit News
White Papers

Retail News Breaks Archives

Week of   

Week of Mon, Apr 29th, 2013

Comp-store sales at Walgreens inch up in April

Walgreen Co. saw comparable-store sales gain slightly in April, as improved pharmacy business and calendar day shifts helped offset the effect of introductions of generic drugs.

New coalition makes medication adherence its mission

CVS Caremark Corp. and the National Association of Chain Drug Stores are among the members of a new national partnership formed to improve medication adherence rates.

Rite Aid reports same-store sales decline for April

An earlier Easter holiday and introductions of lower-priced generic drugs contributed to a same-store sales decrease in April at Rite Aid Corp.

Jean Coutu sees mixed results in 4Q, full year

Despite a sales uptick in its franchise store network, Jean Coutu Group turned in a mixed revenue performance and declined earnings for its 2013 fourth quarter and fiscal year.

New generics boost CVS Caremark's 1Q profit

The influx of new generic drugs hoisted earnings above Wall Street's forecast but tempered sales growth in the first quarter at CVS Caremark Corp.

Walgreens readies opening of Boston flagship store

Walgreen Co. plans to open its latest flagship store tomorrow on School and Washington streets in Boston.

CVS partakes in White House event supporting hiring of veterans

CVS Caremark Corp. was among several national companies represented at an event hosted today by President Barack Obama, Vice President Joe Biden, First Lady Michelle Obama and Dr. Jill Biden as part of the Joining Forces initiative.

Safeway names successor for CEO Burd

Robert Edwards is set to become chief executive officer of Safeway Inc. next month with the retirement of longtime CEO Steve Burd.

NABP calls for global effort to combat illegal online Rx sales

Driven by illicit online sellers, the global distribution of counterfeit drugs and substandard medications demands a global response, the National Association of Boards of Pharmacy (NABP) said in a new report.